# A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge

> **NCT01299467** · PHASE1 · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Active (PF-03526299)
- **DRUG:** Active (PF-03526299)
- **DRUG:** Placebo
- **DRUG:** Active (PF-03526299)
- **DRUG:** Active (PF-03526299)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01299467
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-02
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2011-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01299467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01299467, "A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01299467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*